ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2013

Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.

Helena Tassidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.